The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I find the total and utter lack of confidence in this share really really disheartening, although it's more understandable in the states. The company has displayed hugely positive results that just aren't reflected in the share price. I never thought that I would see this share which I once owned at 13p pre consolidation ( so it would now be worth £6.50 when it's actually worth 65p) I know Rhodi like me held these shares for years and I was very sad but not surprised that he baled out at approx 2p old money. I totally blame JAK for this farce and not the current CEO who seems to be doing his best. Who can can forget the results of phase 2 when rather than concentrating on the positives of the drug results JAK put out the statement that 'it missed its primary goal'
I am amazed the price has held up as well as it has over the Covid weeks. Results for Covid trial are icing on the cake as compound is compelling for key markets anyway.
'Time in the market' not 'timing the market' will ultimately pay off here.
AIMHO and DYOR
Small top up today, hope to add more ahead of Covid trial results.
Looks like all the buys are showing as unknown for some reason.
With quite a few positive trades and the price goes down a penny.
All this so called positive news and it still has a dark satirical link to the Titanic!
Go on Rhodi give it both barrels. This page needs spicing up for Zacc to get his laughing gear round!!!!
Now that rns could have got have got me started when I was holding. LOL
He could ring the bell on the bl—-dy share price!!
Good publicity for us!
What are you expecting to happen in the next few weeks Buddy?
With out a shadow of a doubt in my opinion once the C19 results are announced, if positive a partner will appear. Such a huge and lucrative market $$$$
And very soon! VRP sp always disappointed everyone but the days of the big time are coming in the next few weeks!
My advice is not to be to concerned about people wanting the quick pounds tomorrow-be patient it’s not far away now!
hi tired. seems the market agrees with you as the price hasnt shifted.
Thanks for posting, really interesting.
T&C
Ah, i guess you are waiting for the charge of the penny share brigade. Sadly, they see the news, look at the shares price and run away. Those who remember the penny share days have probably missed the consolidation phase and assume that VRP could be heading back there?
It will take a partnership or something of the like to re-rate VRP is my guess.
As I have said before, the money in drug development isn't in curing diseases, it's in compounds that alleviating symptoms for years!
Our time will come.
AIMHO and DYOR
boom - i hope. see rns.
Link to the Covid study if anyone want to see how things are going:
https://www.clinicaltrials.gov/ct2/show/NCT04527471?term=NCT04527471&draw=2&rank=1
Still currently recruiting and estimate for reporting on primary endpoint is December.
If this works you guys will be laughing. Goodluck to you all and well done for staying the course. If it works FDA approval will be immediate due to the excellent safety profile already proven in trials with over 1300 individuals.If they get the go ahead the Sp will go stratospheric and you will all deserve it. Fingers crossed for you guys. Nice to see some Blue for you.
I must confess im surprised so many are selling off their shares. Unlike COPD we should get the news either officially or through leaks that the drug is working or not and that news is only 30 days away.
Will make sure anything is available if there is the slightest chance it works to get votes!!!
The pilot study seem a little small. If successful outcomes are indicated, won't we then need a much larger trail before FDA would approve ensifentrine?
Just seems like 45 cases is a little slim to draw conclusions on efficacy.
Typo - last post should not say do but sp
Be aware that there may be some short term profit here
-we have all see it before whereby we get good news a sharp rise followed by a sharp fall.
We all know that this drug is safe what we don’t know yet is if it is effective against Covid symptoms.
If it is then as bewise says the results will be out very quickly and approved by the FDA equally as quickly-probably as part of the Presidential elections.
And wow will the do fly if and when it’s approved.
Not long now and COPD to follow.
..who would rather have 100,000 shares in a Company worth nothing than 10,000 shares in VRP.
Maybe some will read the RNS and do the math!
AIMHO and good luck all, our day is coming!
ps....the health need is pretty immediate and not two years down the road therefore fast tracking is the only solution...
Imo this will be brought to market quickly if successful, i discern the indicator clue is in the ceo statement....
"If the pilot study is successful, we are committed to progressing ensifentrine as a treatment for COVID-19 and, if approved, increasing supplies to meet public health needs.”
A quick turn around to get this started, i get a sense of urgency from the RNS. If successful imo i can see this being fast tracked by FDA and on the market within months due to its already proven safety profile and entering P3 for copd.